X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB STRIDES SHASUN LTD UNICHEM LAB/
STRIDES SHASUN LTD
 
P/E (TTM) x 33.1 15.2 218.1% View Chart
P/BV x 3.5 1.8 198.1% View Chart
Dividend Yield % 0.5 0.6 96.8%  

Financials

 UNICHEM LAB   STRIDES SHASUN LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
STRIDES SHASUN LTD
Mar-17
UNICHEM LAB/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs3341,275 26.2%   
Low Rs174918 19.0%   
Sales per share (Unadj.) Rs146.9389.6 37.7%  
Earnings per share (Unadj.) Rs11.928.0 42.5%  
Cash flow per share (Unadj.) Rs16.248.9 33.1%  
Dividends per share (Unadj.) Rs2.004.50 44.4%  
Dividend yield (eoy) %0.80.4 191.8%  
Book value per share (Unadj.) Rs105.1303.1 34.7%  
Shares outstanding (eoy) m90.8489.42 101.6%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x1.72.8 61.4%   
Avg P/E ratio x21.439.2 54.5%  
P/CF ratio (eoy) x15.722.4 70.0%  
Price / Book Value ratio x2.43.6 66.8%  
Dividend payout %16.816.1 104.5%   
Avg Mkt Cap Rs m23,07398,036 23.5%   
No. of employees `0005.75.8 97.8%   
Total wages/salary Rs m2,5585,881 43.5%   
Avg. sales/employee Rs Th2,352.56,005.9 39.2%   
Avg. wages/employee Rs Th450.91,014.0 44.5%   
Avg. net profit/employee Rs Th190.4431.2 44.2%   
INCOME DATA
Net Sales Rs m13,34634,834 38.3%  
Other income Rs m1921,686 11.4%   
Total revenues Rs m13,53836,520 37.1%   
Gross profit Rs m1,6396,428 25.5%  
Depreciation Rs m3901,872 20.8%   
Interest Rs m292,269 1.3%   
Profit before tax Rs m1,4123,973 35.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-44 -102.8%   
Extraordinary Inc (Exp) Rs m-35-1,006 3.5%   
Tax Rs m293470 62.3%   
Profit after tax Rs m1,0802,501 43.2%  
Gross profit margin %12.318.5 66.6%  
Effective tax rate %20.711.8 175.2%   
Net profit margin %8.17.2 112.8%  
BALANCE SHEET DATA
Current assets Rs m5,97938,165 15.7%   
Current liabilities Rs m2,43230,402 8.0%   
Net working cap to sales %26.622.3 119.3%  
Current ratio x2.51.3 195.9%  
Inventory Days Days6377 81.5%  
Debtors Days Days60104 57.8%  
Net fixed assets Rs m6,40337,639 17.0%   
Share capital Rs m182894 20.3%   
"Free" reserves Rs m9,29326,210 35.5%   
Net worth Rs m9,54827,105 35.2%   
Long term debt Rs m23016,377 1.4%   
Total assets Rs m12,84381,168 15.8%  
Interest coverage x50.02.8 1,818.8%   
Debt to equity ratio x00.6 4.0%  
Sales to assets ratio x1.00.4 242.1%   
Return on assets %8.65.9 147.0%  
Return on equity %11.39.2 122.6%  
Return on capital %14.312.1 119.0%  
Exports to sales %29.20-   
Imports to sales %6.30-   
Exports (fob) Rs m3,900NA-   
Imports (cif) Rs m847NA-   
Fx inflow Rs m4,35613,465 32.4%   
Fx outflow Rs m1,1624,076 28.5%   
Net fx Rs m3,1949,389 34.0%   
CASH FLOW
From Operations Rs m1,1192,881 38.8%  
From Investments Rs m-853-7,051 12.1%  
From Financial Activity Rs m-3343,382 -9.9%  
Net Cashflow Rs m-68-788 8.7%  

Share Holding

Indian Promoters % 50.1 27.7 180.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 37.8 39.9%  
FIIs % 3.0 8.6 34.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 25.9 122.4%  
Shareholders   20,176 56,241 35.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 22, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS